Upload Avatar (500 x 500)
Fang Ni
Basic Medical Sciences
University of Science and Technology of China
Anhui
Language: English, Chinese
Hematopoiesis
Leukemia
Regulation
Pathogenesis
Nk Cells
Immunotherapy
Biomechanics
Metabolism
Multidisciplinary
Homeostasis
Areas of Focus
- Hematopoietic regulation and leukemia pathogenesis
- NK cell immunotherapy
Work Experience
- 2019-present - University of Science and Technology of China, School of Life Sciences and Medicine, Principal Investigator
Academic Background & Achievements
- 2013 - PhD: University of Science and Technology of China, School of Life Sciences
- 2015-2019 - Postdoctoral Research: Emory University Hospital, USA
Publications
- Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia., Wang Y, Huang B, Liang T, Jiang L, Wu M, Liu X, Zhu M, Song X, Zhao N, Wei H*, Zheng C*, Ni F*., 2024
- Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19., Guo C#, Wu M#, Huang B#, Zhao R, Jin L, Fu B, Wang P, Wang D, Zheng M, Fang J, Wei H*, Qu K*, Ni F*., 2022
- Ptpn21 controls hematopoietic stem cell homeostasis and biomechanics., Ni F, Yu WM, Wang XY, Fay ME, Young KM, Qiu YZ, Lam WA, Sulchek TA, Cheng T, Scadden DT, and Qu CK*., 2019
- Critical role of ASCT2-mediated amino acid metabolism in promoting leukemia development and progression., Ni F, YuWM, Li ZG, GrahamDK, JinLT, Kang S, RossiMR, LiSY, BroxmeyerHE, and Qu CK*., 2019
- IGF-1 promotes the development and cytotoxic activity of human NK cells., Ni F, Sun R, Fu B, Wang F, Guo C, Tian Z*, Wei H*., 2013
